Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Invitation to a conference call and webcast in connection with Isofol receiving recommendation to complete the global Phase III AGENT study for market registration as planned with 440 patients

GOTHENBURG, Sweden, March 22, 2021 - Isofol Medical AB (publ) (“Isofol”), (Nasdaq First North Premier Growth Market: ISOFOL) announced on 19 March 2021 that the independent Data Safety and Monitoring Board (iDSMB) has recommended continuation of the global Phase III AGENT study with 440 patients, in accordance with the study design for the drug candidate, arfolitixorin. In connection with this, Isofol invites investors, analysts and media to a conference call and webcast on March 22, 2021 at 14:00 (CET).The presentation will be held by Isofol's CEO Ulf Jungnelius in English and will

Sectra helps civil authorities and large corporations protect their digital communication with a service that supplements existing products

Linköping – March 22, 2021 – International cybersecurity and medical imaging IT company Sectra  (STO: SECT B) is supplementing its offering of secure communication systems with a new service for secure digital communication and remote collaboration. The service will allow Swedish civil authorities and large corporations to communicate more efficiently without jeopardizing the security of their mobile communication between different platforms, such as iPhone, Android, Windows and Mac. The new service will enable voice communication and video conferencing with a high level

Leading international competence recruited to the board of Hamlet Pharma

As previously announced, the Extraordinary General Meeting  of Hamlet Pharma held on the 4[th ]of March, elected Professor Bill Hansson to the board of Hamlet Pharma.Bill Hansson was until recently Vice President of the Max Planck Society. In this capacity he facilitated the progress of science in Germany and internationally and during his leadership, the organization has flourished, as illustrated e.g. by the recent Nobel Prize awards. Bill Hansson has also overseen the translation of scientific innovations for public and commercial use and spearheaded a new human resources and

Crunchfish presents at All Digital Week - How will we pay in the future?

Sweden is the country that uses cash the least in the world, and the pandemic has decreased the use of cash even more. We are also becoming increasingly dependent on the network when we pay. On Friday 26[th] of March at 13.00, Joachim Samuelsson - CEO of Crunchfish - will present how we become independent of the net when we pay, which solves a number of problems that the world faces when the cash disappears. Crunchfish offers a digital cash wallet  for the world's payment services, either on your mobile or on a prepaid

Autoliv Nominates Directors for Election at the 2021 Annual Stockholders Meeting

(Stockholm, Sweden, March 22, 2021) – Autoliv, Inc. (NYSE: ALV and SSE: ALIVsdb), the worldwide leader in automotive safety systems, today announced its nominees for election by the stockholders to the Board of Directors at the 2021 Annual Stockholders Meeting, including Mr. Martin Lundstedt, President and Chief Executive Officer of AB Volvo as a new nominee for the Board.The Board of Directors (the “Board”) approved the nomination of Mr. Martin Lundstedt for election at the Annual General Meeting of Stockholders (the “2021 Annual Meeting”). Mr. Lundstedt, age 54, has served as President of

Bravida strengthens its position in ventilation in Malmö – acquires IEAB installationsentreprenören AB

Bravida acquires IEAB, thus giving it a stronger position in the ventilation segment in Malmö. IEAB currently has sales of around SEK 75 million and 23 employees.Founded in 2013, IEAB specialises in energy-efficient and cost-effective ventilation solutions in technologically complicated projects. Its major customers are mainly construction companies, but work is also done directly for end customers as well. “IEAB is an exciting and very well-run company which we are very pleased to welcome to Bravida. The acquisition will strengthen our position in ventilation in the region and we

Notice of Annual General Meeting in Rejlers AB (publ)

The shareholders of Rejlers AB (publ) (the “Company”), reg. no 556349-8426, are hereby summoned to the Annual General Meeting on Thursday, 22 April 2021 at 4:00 p.m. at Lindhagensgatan 126, floor 3, in Stockholm, Sweden. Registration for the meeting commences at 3:30 p.m.Notification Shareholders who wish to participate in the Annual General Meeting must: i. both be recorded as shareholders in the share register kept by Euroclear Sweden AB on the record date of Wednesday 14 April 2021; andii. have notified their participation to the Company not later than Friday 16 April 2021;

Notice to the Annual General Meeting

Tele2 AB (publ), reg. no. 556410-8917, with its registered office in Stockholm, Sweden, hereby gives notice to the Annual General Meeting on Thursday 22 April 2021.The continued spread of COVID-19 remains difficult to assess with anycertainty. Due to the prevailing extraordinary situation, Tele2’s AnnualGeneral Meeting will be held in a different way than usually. Tele2 is mindfulof the health of the shareholders as well as the work to limit the spread ofthe virus. Thus, in order to reduce the risk of spreading the virus and havingregard to the authorities’ regulations and advice

Trading of own shares as part of employee’s bonus scheme

SpareBank 1 SR-Bank ASA has on 19 March 2021 purchased 40 000 own shares at an average price of NOK 105,5503. Total holdings of own shares after the purchase is 63.112 shares. The shares were acquired as part of SpareBank 1 SR-Bank’s bonus scheme where part of the settlement takes place through the allocation of shares. As part of SpareBank 1 SR-Bank ASA bonus scheme the company will acquire additional shares, up to a number of 50.000, within the end of March 2021.

Realheart initiates chronic animal trials today

In accordance with Realheart's development plan for 2021, the chronic animal trials that were postponed due to the pandemic are starting today. This has been made possible thanks to new technology that allows Realheart to participate in the studies remotely.Animal study data is required to obtain approval to initiate clinical trials, and studies are conducted to identify any product design problems that cannot be detected by other test methods. Animal studies require ethical approval, which is usually given in two steps. Firstly, an approval to perform acute studies for up to 24 hours,

Saga Pure ASA: Private placement in Bergen Carbon Solutions and listing on Euronext Growth

(Oslo, 22 March 2021) Saga Pure ASA (Saga, OSE: SAGA) has entered into agreements to subscribe for NOK 15 million in a private placement in Bergen Carbon Solutions AS (Bergen Carbon Solutions). The company contemplates raising NOK 80 million in new equity and intends to apply for trading on Euronext Growth Oslo.“Bergen Carbon Solutions uses innovative, patented and award-winning technologies to produce carbon nanofibers from captured CO\2\. The production is emission free and we look forward to continue to support the team in the commercialization of this truly unique technology as a listed

Kiilto continues to strengthen its position as the Nordic expert for professional hygiene

Kiilto has continued its growth in the Scandinavian cleanliness and hygiene market. Environmental focus is strong and a part of all new launches across markets.During the exceptional year of 2020 Kiilto’s expertise in hygiene and especially in hand hygiene and disinfection became vital. All Scandinavian countries have a long history within personal hygiene, and it has been a key factor in introducing also new products to the markets. “In challenging times, we have wanted to help our community the best way we can. With the Kiilto Pro product range we have helped new restaurants to open

Annual General Meeting in AQ Group AB (publ) on April 21, 2021

The Annual General Meeting in AQ Group AB (publ) will be held on Wednesday, April 21, 2021 in Västerås, Sweden.Notice of the Annual General Meeting, with proposed agenda is included in its entirety in this press release and is published on the company web page www.aqg.se . The notice of the meeting is published in "Post- och Inrikes Tidningar" and an announcement with information that the notice has been issued is published in Dagens Industri, on March 22, 2021. Information regarding COVID-

Caverion completed a new project for Thermo Fisher Scientific in Lithuania – in just four months

Caverion Corporation Investor news 22 March 2021 at 9.00 a.m. EETCaverion completed a new project for Thermo Fisher Scientific in Lithuania – in just four months Caverion implemented a turnkey project for a new building of the biotechnology company Thermo Fisher Scientific Baltics. The project was implemented in Vilnius, Lithuania, in just four months with a total area of 5,500 square meters. Caverion was responsible for the Design&Build phases for all technical building solutions. The project also included class C and D cleanroom facilities of 2,300 square meters. “

AZD1222 US Phase III trial met primary efficacy endpoint in preventing COVID-19 at interim analysis

22 March 2021 07:00 GMT AZD1222 US Phase III trial met primary efficacy endpoint in preventing COVID-19 at interim analysis 79% vaccine efficacy at preventing symptomatic COVID-19 100% efficacy against severe or critical disease and hospitalisation Comparable efficacy result across ethnicity and age,with 80% efficacy in participants aged 65 years and over Favourable reactogenicity and overall safety profile   The AstraZeneca US Phase III trial of AZD1222 demonstrated statistically significant vaccine efficacy of 79% at preventing symptomatic COVID-19 and 100% efficacy

Metso Outotec receives order for a mine conveyor system in South America

Metso Outotec Corporation’s press release on March 22, 2021, at 09:00 a.m. EETMetso Outotec has received an order for a heavy-duty mine conveyor system in South America. The delivery consists of high reliability overland conveyors, including a 2-km single flight conveyor. Equipment provided in this package runs at speeds of up to 6 m/s with a delivery capacity of over 9,000 t/h. The order value is approximately EUR 10 million and it has been booked in Minerals’ Q1/2021 orders received. “Metso Outotec’s full range of overland conveyor solutions provides economic and reliable material

DOMETIC PUBLISHES THE 2020 ANNUAL AND SUSTAINABILITY REPORT

Dometic Group AB (publ) today announces that the company’s 2020 Annual and Sustainability Report is now published and available at www.dometic.com/en/se/about-us/investors. The 2020 Remuneration report is published and available at the dometic.com site for Corporate governance . This information is information that Dometic Group AB (publ) is obliged to make public pursuant to the Securities Markets Act. The information was submitted for publication at 08:00 CET on  March 22, 2021. FOR FURTHER INFORMATION,

Peab rebuilds Highway 35 south of Linköping

Peab has been commissioned to rebuild Highway 35 south of Linköping on the stretch between Sandtorpet and Björkåkla. The customer is the Swedish Transport Administration and the contract is worth SEK 122 million.The road between Sandtorpet and Björkåkla will be broadened and rebuilt into a divided 2+1 highway with a center guardrail along an 8.5 kilometer stretch of the road. At the same time measures will be taken to strengthen mass transit. “Naturally we are pleased to contribute to improving traffic safety and passability on Highway 35. One of the challenges with the project is

Phase II results published in medical journal and Redwood Pharma to present poster at medical meeting

The results of Redwood Pharma's Phase II study of RP101 have now been published in the medical journal Advances in Therapy and will also be presented as a scientific poster presentation at the forthcoming annual meeting of the Association for Research in Vision and Ophthalmology (ARVO).In 2020, Redwood Pharma completed a Phase II clinical trial in Europe of RP101, the company's drug candidate for the treatment of chronic dry eye in post-menopausal women. The results have now been published in Advances in Therapy, an international scientific journal in clinical medicine. See link:

Notice convening the Annual General Meeting of Electrolux Professional AB (publ)

The shareholders of Electrolux Professional AB (publ), reg. no. 556003-0354, are hereby given notice of the Annual General Meeting to be held on Wednesday, April 28, 2021.Due to the coronavirus, the Board of Directors has decided that the Annual General Meeting should be conducted without the physical presence of shareholders, representatives or third parties and that the shareholders should be able to exercise their voting rights only by post before the meeting. Information on the resolutions passed at the meeting will be disclosed on April 28, 2021, as soon as the outcome of the postal

Bexmarilimab (Clevegen) development update

Faron Pharmaceuticals Oy (“Faron” or the “Company”) Bexmarilimab (Clevegen) development update · Significant survival benefit observed in patients responding to bexmarilimab treatment with risk of death reduced by 88% · Gastric cancer becomes sixth tumour cohort to show early signs of clinical efficacy · Data monitoring committee recommends dose escalation expansion in all six cohort types besides ongoing colorectal cancer Company announcement, 22 March 2021 at 9.00 AM (EET)Inside information TURKU – FINLAND – Faron Pharmaceuticals Oy (AIM: FARN, First North: FARON),

DanCann Pharma A/S: CEO Jeppe Krog Rasmussen upgrades his shareholding in DanCann Pharma A/S, and now holds more than 26% of the Company

COPENHAGEN, Denmark, 22 March 2021 - DanCann Pharma A/S (SS: DANCAN) (“DanCann Pharma” or the “Company”) hereby announce that Jeppe Krog Rasmussen, Founder, Board Member and CEO at DanCann Pharma A/S has privately through his holding company (JKR INVESTMENT GROUP ApS) bought 50,000 shares in DanCann Pharma A/S at an average price of DKK 3.25 per share.The shares were purchased in the ongoing trading on Spotlight Stock Market on Friday 19 March 2021. Following this transaction, Jeppe Krog Rasmussen now directly through his holding company (JKR INVESTMENT GROUP ApS) controls 5,430,000

Höegh LNG: Revised bond amendment terms

Hamilton, Bermuda 22 March 2021 - Höegh LNG Holdings Ltd. ("Höegh LNG" or the "Company") has today instructed Nordic Trustee AS as trustee for its senior unsecured bond issues maturing in February 2022 (ISIN NO 0010782949) (“HLNG03”) and January 2025 (ISIN NO 0010873755) (“HLNG04”) to make certain revisions to the proposed bond amendments (the “Amendment Proposal”) announced on 8 March 2021. Following discussions with bondholders, HLNG has requested certain adjustments to the Amendment Proposal. The revised proposal is set out in the attached addendum to summons. The revised proposal has

There are no items matching the current filter
There are no more items matching the current filter
Back to top